Interferon zeta-like precursor, a vital component of the immune system, plays a pivotal role in the host's defense against viral infections. This protein's primary function lies in its ability to induce the production of interferons, which are key signaling molecules in the immune response. Interferons act as potent antiviral agents by alerting neighboring cells to the presence of a viral infection and activating a variety of antiviral defense mechanisms. Activation of interferon zeta-like precursor involves intricate molecular processes that are crucial for its functionality. It can be directly activated by specific pathogen-associated molecular patterns (PAMPs) or ligands that interact with Toll-like receptors (TLRs), such as TLR3, TLR7, and TLR8. These receptors recognize viral RNA or other pathogenic components, triggering a cascade of intracellular events that culminate in the activation of interferon zeta-like precursor. Additionally, interferon zeta-like precursor can be indirectly activated through various cellular pathways, including NF-κB, JAK-STAT, and PKR. These pathways are interconnected with the immune response and can be stimulated by a range of signals, such as proinflammatory cytokines or stress responses. Once activated, interferon zeta-like precursor promotes the expression of interferons, which, in turn, activate an array of antiviral defenses, including the upregulation of antiviral genes, inhibition of viral replication, and recruitment of immune cells to the site of infection.
In summary, interferon zeta-like precursor serves as a critical player in the immune system's response to viral threats. Its primary function involves orchestrating the production of interferons, which initiate a series of antiviral defenses. The protein can be directly activated by viral components through TLRs or indirectly through various cellular pathways, ensuring a rapid and effective immune response against viral infections. Understanding the mechanisms of interferon zeta-like precursor activation is fundamental to unraveling the complexities of antiviral immunity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
R-848 is a TLR7 agonist that directly activates the interferon zeta-like precursor by binding to TLR7 and subsequently triggering downstream signaling pathways that lead to the activation of interferon zeta-like precursor. It activates the protein by inducing the expression of interferon genes. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod is another TLR7 agonist that activates interferon zeta-like precursor through the same mechanism as Resiquimod, by binding to TLR7 and promoting the expression of interferon genes. | ||||||
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
Poly(I:C) is a synthetic double-stranded RNA molecule that directly activates the interferon zeta-like precursor by interacting with TLR3, leading to the initiation of downstream signaling pathways that activate the protein. | ||||||